Gene Therapy Fast Tracked for Rare Congenital Skin Disorder – Monthly Prescribing Reference (registration)
|
Gene Therapy Fast Tracked for Rare Congenital Skin Disorder
Monthly Prescribing Reference (registration) Fibrocell Science announced that the Food and Drug Administration (FDA) has granted Fast Track designation to FCX-007 for the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB). RDEB is a rare, congenital, debilitating genetic skin disorder … Fibrocell Science (FCSC) Receives FDA Fast Track Designation of FCX-007 for Treatment of RDEB |
